Extract notice to the Minister

Xalkori

Common name / Subject : crizotinib
Name of the manufacturer : Pfizer
Form : Caps.
Dosage : 200 mg, 250 mg

Indication :

INESSS' Recommendation
Sous étude

Minister's decisions
Information actuellement non disponible en ligne

Evaluation published on June 03, 2013

Subscribe to our newsletter now

Subscription